How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC Published 2022-05-17 Download video MP4 360p Download video MP4 720p Recommendations 27:32 Lung Cancer Staging 41:58 Testing for Common and Uncommon EGFR Mutations to Guide EGFR-Targeted Therapy in NSCLC 1:27:19 The Art of Aging Well 55:10 CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine 2:16:45 Immuno-Oncology Symposium - Part 1 46:01 Drs. Goyal & Salem discuss #HCC at #SIOLongBeach - https://bit.ly/LongBeach24Y 1:32:16 An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar 42:55 EGFR-Targeted Therapy for Early-Stage NSCLC: What Thoracic Surgeons Need to Know 58:37 Immuno-oncology: Cold to Hot Tumours 53:40 North Korea and the new Cold War | 60 Minutes Full Episodes 2:24:07 2023 HMS/HSDM White Coat Ceremony 1:20:46 Hodgkin Lymphoma: history and its mimics 04:38 Difference Between Immunotherapy, Targeted Therapy and Chemotherapy 1:06:54 Beyond the Horizon in Gastric Cancer: Updated Evidence on How Systemic Therapies Are Redefining Care 49:56 Reshaping the Future of Lung Cancer Treatment With TROP2-Targeting ADCs and Rational Combinations 43:46 Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC 23:53 Equitably Empowering Our Upper GI Cancer Patients Using Plain Language Tools 1:13:49 Adopting TIC in Rural Areas: Lessons from a Community Behavioral Health Partnership in Pennsylvania 26:47 Colon Care- Diverticulosis and Diverticulitis 1:30:26 The Science of Pain Management Similar videos 03:08 Choosing immunotherapy as front line therapy for non-actionable NSCLC 03:59 Second-line Treatment for Nondriver Metastatic NSCLC 05:17 ASCO: Combination Immunotherapy for First-Line Treatment of Advanced Lung Cancer 01:07 NAUTIKA1: targeted therapies in biomarker-selected stage IB-II NSCLC 06:31 How To choose first line therapy in melanoma? 10:36 Patient Selection for Immunotherapy in LA NSCLC 1:44:45 Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy 37:23 NSCLC: Integrating EGFR-Inhibiting Therapies into Clinical Pathways for First-Line Treatment 05:57 SCLC Therapy: First-line Options Prior to Immunotherapy 00:48 Chemotherapy-free immunotherapy-based treatment approaches for NSCLC 03:46 Immunotherapy as First-Line Treatment 04:39 Treatment for EGFR+ NSCLC 12:50 Avastin-containing regimen for first line and maintenance therapy in advanced NSCLC 1:39:03 Everything You Need to Know About Biomarker Testing and Treatment of Genomically Altered NSCLC 02:22 Moving immunotherapy to earlier lines in NSCLC 22:08 Immunotherapy in NSCLC 44:56 Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape 08:18 Case Based Panel Discussion - EGFR and High PDL-1, Choosing Targeted Therapy or Immunotherapy More results